Identification of additional Hereditary Angioedema (HAE) types with normal C1 esterase inhibitor has highlighted the role of genetic testing in the diagnosis and management of HAE. The objective of this study is to assess healthcare providers’ (HCPs) current experiences, practices, and comfort level with genetic testing in patients at risk for Hereditary Angioedema (HAE).